Controlling Post-extraction Complications of Impacted Mandibular Third Molar

Sponsor
Al-Azhar University (Other)
Overall Status
Completed
CT.gov ID
NCT04816253
Collaborator
(none)
72
1
4
4.3
16.9

Study Details

Study Description

Brief Summary

Impacted mandibular 3rd molar will be extracted in all patients, then patients will be divided, according to material placed in extraction socket into 3 groups: control, hyaluronic acid and honey. Then post extraction complications will be evaluated

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

Impacted Mandibular third molar will be extracted under local anesthesia Through standard surgical flap elevation, after extraction and wound irrigation a material facilitate healing will be placed. According to material will be placed patients will be divide into 3 group: control ( no material, second group hyaluronic acid, third group ( honey).. then wound will be closed. Postoperative pain ( through visual analog scale) , edema, total dose of analgesic, mandibular movement (interincisal distance in mm) will be evaluated preoperative, 1,2,3,7, and 10 day after extraction

Study Design

Study Type:
Interventional
Actual Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Methylprednisolone and Hyaluronic Acid Versus Each Agent Alone to Control Post-extraction Complications of Impacted Mandibular Third Molar
Actual Study Start Date :
Feb 10, 2021
Actual Primary Completion Date :
Jun 20, 2021
Actual Study Completion Date :
Jun 20, 2021

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Normal saline

Normal saline irrigation after extraction and No drug placed in tooth socket

Drug: Normal saline
Normal saline irrigation and No other drug placed after extraction

Active Comparator: Gengigel

Gengigel (Hyaluronic acid) placed after extraction

Drug: Hyaluronic acid
Immediately after removal of impacted tooth (hyaluronic acid) placed in extraction socket
Other Names:
  • Gengigel
  • Active Comparator: Methylprednisolone

    Methylprednisolone will be given intravenous to a patient half an hour before the surgery

    Drug: Methylprednisolone
    Methylprednsolone will be injected half an hour preoperatively

    Active Comparator: Methylprednisolone and Gengigel

    Methylprednisolone will be given intravenous to a patient half an hour before the surgery and Gengigel (Hyaluronic acid) placed after extraction

    Drug: Methylprednisolone and Hyaluronic acid
    Methylprednisolone will be injected half an hour preoperatively and Immediately after removal of impacted tooth (hyaluronic acid) placed in extraction socket

    Outcome Measures

    Primary Outcome Measures

    1. Interincisal distance [Baseline (Preoperative)]

      Measuring distance between upper lower anterior teeth in mm

    2. Interincisal distance [1 day postoperative]

      Measuring distance between upper lower anterior teeth in mm

    3. Interincisal distance [2nd day postoperative]

      Measuring distance between upper lower anterior teeth in mm

    4. Interincisal distance [3rd day postoperative]

      Measuring distance between upper lower anterior teeth in mm

    5. Interincisal distance [7th day postoperative]

      Measuring distance between upper lower anterior teeth in mm

    6. Assessment of pain using Visual analog scale [Baseline (Preoperative)]

      Patient asked to describe pain intensity subjectively on visual analog scale where 0 mean no pain while 10 mean sever pain

    7. Assessment of pain using Visual analog scale [1st day]

      Patient asked to describe pain intensity subjectively on visual analog scale where 0 mean no pain while 10 mean sever pain

    8. Assessment of pain using Visual analog scale [2nd day]

      Patient asked to describe pain intensity subjectively on visual analog scale where 0 mean no pain while 10 mean sever pain

    9. Assessment of pain using Visual analog scale [3rd day]

      Patient asked to describe pain intensity subjectively on visual analog scale where 0 mean no pain while 10 mean sever pain

    10. Assessment of pain using Visual analog scale [7th day]

      Patient asked to describe pain intensity subjectively on visual analog scale where 0 mean no pain while 10 mean sever pain

    11. Total amount of analgesic [1st day postoperative]

      Total amount of analgesic Will be calculated

    12. Total amount of analgesic [2nd day postoperative]

      Total amount of analgesic Will be calculated

    13. Total amount of analgesic [3rd day postoperative]

      Total amount of analgesic Will be calculated

    14. Total amount of analgesic [7th day postoperative]

      Total amount of analgesic Will be calculated

    15. Size of edema will be assessed from finial angle and Travis of ear to mental ala of Nes and mouth angle [Baseline]

      Edema measured from gonial angle and Tragus to mental, angle of mouth, ala of nose, and lateral canthus of eye respectively

    16. Size of edema will be assessed from finial angle and Travis of ear to mental ala of Nes and mouth angle [1st day postoperative]

      Edema measured from gonial angle and Tragus to mental, angle of mouth, ala of nose, and lateral canthus of eye respectively

    17. Size of edema will be assessed from finial angle and Travis of ear to mental ala of Nes and mouth angle [2nd day postoperative]

      Edema measured from gonial angle and Tragus to mental, angle of mouth, ala of nose, and lateral canthus of eye respectively

    18. Size of edema will be assessed from finial angle and Travis of ear to mental ala of Nes and mouth angle [3rd day postoperative]

      Edema measured from gonial angle and Tragus to mental, angle of mouth, ala of nose, and lateral canthus of eye respectively

    19. Size of edema will be assessed from finial angle and Travis of ear to mental ala of Nes and mouth angle [7th day postoperative]

      Edema measured from gonial angle and Tragus to mental, angle of mouth, ala of nose, and lateral canthus of eye respectively

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 35 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • healthy patients

    • patient has impacted 3rd molar

    Exclusion Criteria:
    • medically compromised patients Heavy smoking patients

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Vision college Jeddah Saudi Arabia

    Sponsors and Collaborators

    • Al-Azhar University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alaa Altaweel, Associate professor, Al-Azhar University
    ClinicalTrials.gov Identifier:
    NCT04816253
    Other Study ID Numbers:
    • Extraction healing
    First Posted:
    Mar 25, 2021
    Last Update Posted:
    Jul 22, 2021
    Last Verified:
    Jul 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 22, 2021